Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3138-3144

  Liu, Chun ^a   Lian, Fuzhi ^a   Smith, Donald E ^a   Russell, Robert M ^a   Wang, Xiang Dong ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; CYCLINE; LYCOPENE; PROTEIN BAD; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; FERRET; GENE OVEREXPRESSION; HISTOPATHOLOGY; ISOMER; LUNG CANCER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL METAPLASIA;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; CAROTENOIDS; CARRIER PROTEINS; CASPASE 3; CASPASES; CELL DIVISION; DIETARY SUPPLEMENTS; DRUG EVALUATION, PRECLINICAL; ENVIRONMENTAL EXPOSURE; FERRETS; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; ISOMERISM; LUNG; MALE; METAPLASIA; MODELS, ANIMAL; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SMOKE; TOBACCO;

EID: 0038407714     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Peto, R., Doll, R., Buckley, J. D., and Sporn, M. B. Can dietary beta carotene materially reduce human cancer rates? Nature (Lond.), 290: 201-208, 1981.
2. Ziegler, R. G., Mayne, S. T., and Swanson, C. A. Nutrition and lung cancer. Cancer Causes Control, 7: 157-177, 1996.
3. Mayne. S. T. β-Carotene, carotenoids, and disease prevention in humans. FASEB J., 10: 690-701, 1996
4. Heber, D. Colorful cancer prevention: alpha carotene, lycopene, and lung cancer. Am. J. Clin. Nutr., 72: 901-902, 2000.
5. Hennekens, C. H., Buring, J. E., Mangon, J. E., Stampfer, M. Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., Willett, W., and Peto, R. Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplaims and cardiovascular disease. N. Engl. J. Med., 334: 1145-1149, 1996.
6. The Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med., 330: 1029-1035, 1994.
7. Omenn, G. S., Goodman, G., Thornquist, M., Grizzle, J., Rosenstock, L., Barnhart, S., Balmes, J., Cherniack. M. G., Cullen, M. R., Glass, A., et al. The β-carotene and retinol efficacy trial (CARET) for chemoprevention of lung caner in high risk populations: smokers and asbestos-exposed workers. Cancer Res., 54: 2038-2043s, 1994.
8. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B. Williams, J. H., Barnhart, S., and Hammar, S. Effects or a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med., 334: 1150-1155, 1996.
9. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A., and Williams, W. C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. (Bethesda), 87: 1767-1776, 1995.
10. Clinton, S. K., Erdman, C., Schwartz, S. J., Biomark, D. G., Williams A. W., Moore, B. J., and Erdman, J. W., Jr. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate, Cancer Epidemiol. Biomark, Prev. Biomark. Prev., 5: 823-833, 1996.
11. Giovanni, E. Tomatoes, tomato based products, lycopene, and cancer: review of the epidemiologic literature. J. Natl. Cancer Inst. (Bethesda), 91: 317-331, 1999.
12. Gann, P. H., Ma, J., Giovannucci, E., Willett, W., Sacks, F. M., Hennekens, C. H., and Stampfer, M. J. Lower proslate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res., 59: 1225-1230, 1999.
13. Kucuk, O., Sarkar, F. H., Sakr, W. Djuric, Z., Pollak, M. N., Khachik, F., Li, Y. W., Banerjee, M., Grignon, D., Bextram, J. S., Crissman, J. D., Pontes, E. J., and Wood, D. P., Jr. Phase 1I randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomark. Prev., 10: 861-868, 2001.
14. Kim, D. J., Takasuka, N., Kim, J. M., Sekine, K., Ota, T., Asamoto, M., Murakoshi, M., Nishino, H., Nir, Z., and Tsuda, H. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU, and DMH. Cancer Lett., 120: 15-22, 1997.
15. Stahl, W., and Sies, H. Lycopene: a biologically important carotenoid for humans? Arch. Biohem. Biophys., 336: 1-9 1996.
16. Agarwal, S., and Rao, A. V. Carotenoids and chronic diseases. Drug Metabol. Drug Interact., Interact., 17: 189-210, 2000.
17. Bertram, J. S. Carotenoids and gene regulation. Nutr. Rev., 57: 182-191, 1999.
18. Stahl, W., and von Laar, J., Martin, H.D., Emmerich, T., and Sies, H. Stimulation of gap-junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch. Biochem. Biophys., 373: 271474, 2000.
19. Levy, J., Bosin, E., Feldman, B., Giat, Y., Miinster, A., Danilenko, M., and Sharoni, Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr. Cancer, 24: 257466, 1995.
20. Karas, M., Amir, H., Fishman, D., Danilenko, M., Segal, S., Nahum, A., Koifmann, A., Gial, Y., Levy, J., and Sharoni, Y. Lycopone interferes with cell cycle progression and insulin-like growth factor 1 signaling in mammary cancer cells. Nutr. Cancer, 36: 101-111, 2000.
21. Bertram, J. S., and Bortkiewicz, H. Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am. J. Clin. Nutr., 62: 1327S-1336S, 1995.
22. Yu, H., and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. (Bethesda), 92: 1472-1489, 2000.
23. Giovannucci, E. Insulin-like growth factor-1 and binding protein-3 and risk of cancer. Horm. Res., 51 (Suppl. 3): 34-41, 1999.
24. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 nol BCL-X(L). Cell, 87: 619-628, 1996.
25. Zhou, X. M., Liu, Y., Payne, G., Lutz, R. J., and Chiltenden, T. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J. Biol. Chem., 275: 25046-25051, 2000.
26. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez. G. Interleukin-3-induced phosphorylation of BAD through the protei kinase Akl. Science (Wash. DC). 278: 687-689, 1997.
27. Peruzzi, F., Prisco, M., Dews, M., Salomoni, P., Grassilli, E., Romano, G., Calabrella, B., and Baserga, R. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol. Cell. Biol., 19: 7203-7215, 1999.
28. Shimamum, A., Ballif, B. A., Richards, S. A., and Blenis, J. Rsk1 mediales a MEK-MAP kinase cell survival signal. Cure Biol., 10: 127-135, 2000.
29. Gibnore, A. P., Valenlijn, A. J., Wang, P., Ranger, A. M., Bundred, N., O'Hare M. J., Wakeling, A., Korsmeyer, S. J., and Streuli, C. H. Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. J. Biol. Chem., 277: 27643-27650, 2002.
30. Rechler, M. Growth inhibition by insulin-like growth factor (IGF) binding protein-3: what's IGF got to do with it? Endocrinology, 138: 2645-2647, 1997.
31. Liu, B., Lee, H. Y., Weinzimer, S. A., Powell, D. R., Clifford, J. L., Kurie, J. M., and Cohen, P. Direct functional interactions between insulin like growth factor binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J. Biol. Chem., 275: 33607-33613, 2000.
32. Oh, Y., Muller, H. L., Lamson, G., and Rosenfeld, R. G. Insulin-like growth factor (IGF)-independent action of IGF binding protein 3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J. Biol. Chem., 268: 14964-14971, 1993.
33. Lee, H. Y., Chun, K. H., Liu, B., Wiehle, S. A., Cristiano, R. J., Hong, W. K., Cohen, P., and Kurie, J. M. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Cancer Res., 62: 3530-3537, 2002.
34. Hochscheid, R., Jaques, G., and Wegmann, B. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and iumorigeniety: a cell culture model for lung cancer. J. Endocrinol., 166: 553-563, 2000.
35. Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., and Wu, X. Plasma levels of insulin-like growth factor 1 and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst. (Bethesda), 91: 151-156, 1999.
36. London, S. J., Yuan, J. M., Travlos, G. S., Gao, Y. T., Wilson, R. E., Ross, R. K., and Yu, M. C. Insulin-like growth factor 1, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J. Natl. Cancer Inst. (Bethesda), 94: 749-754, 2002.
37. Wakai, K., Ito, Y., Susuki, K., Tamakoshi, A., Seki, N., Ando, M., Ozasa, K., Watanabe, Y., Kondo, T., Nishino, Y., and Ohno, Y. Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study. Jpn. J. Cancer Res., 93: 1279-1286, 2002.
38. Chang, Y. S., Kong, G., Sun, S., Liu, D., El-Naggar, A. K., Khuri, F. R., Hong, W. K., Lee, H. Y., and Gong, K. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage 1 non-small cell lung cancer. Clin. Cancer Res., 8: 3796-3802, 2002.
39. Kaklamani, V. G., Linos, A., Kaklamani, E., Markaki, I., and Mantzoros, C. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J. Clin. Oncol., 17: 813-817, 1999.
40. Mucci, L. A., Tamimi, R., Lagiou, P., Trichopoulou, A., Benetou, V., Spanos, E., and Trichopoulos, D. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int., 87: 814-820, 2001.
41. Holmes, M. D., Pollak, M. N., Willett, W. C., and Hankinson, S. E. Dietary Correlates of plasma insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations. Cancer Epidemiol. Biomark. Prev., 11: 852-861, 2002.
42. Ferreira, A. L., Yeum, K. J., Liu, C., Smith, D., Krinsky, N. I., Wang, X. D., and Russell, R. M. Tissue distribution of lycopene in farrets and rats after lycopene supplementation. J. Nutr., 130: 1256-1260, 2000.
43. Wang, X. D., Krinsky, N. I., Marini, R. P., Tang, G., Yu, J., Hurley, R., Fox. J. G., and Russell, R. M Intestinal uptake and lymphatic absorption of β-carotene in ferrets: a model for human β-carotene metabolism. Am. J. Physiol., 263: G480-3486, 1992.
44. Wang, X. D., Liu, C., Bronson, R. T., Smith, D. E., Krinsky, N. I., and Russell, M. Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. (Bethesda). 91: 60-66, 1999.
45. Sindhu, R. K., Rasmussen, R. E., and Kikkawa, Y. Exposure tobacco smoke results in an increased production of (+)-anti-bonzol[a]pyrene-7,8-dihydrodiol-9.10-epoxide in juvenile ferret lung homogenates. J. Toxicol. Environ. Health, 47: 523-534, 1996.
46. Sindhu, R. K., Rasmussen, R. E., and Kikkawa, Y. Effect of environmental tobacco smoke on the metabolism of (-)-trans-benzo[alpyrene-7,8-dihydrodiol in juvenile ferrel lung and liver. J. Toxicol. Environ. Health, 45: 453-464, 1995.
47. Vinegar, A., Sinnen, E. E., Kosch, P. C., and Miller, M. L. Pulmonary physiology of the ferrel and its potential as a model for inhalation toxicology. Lab. Anim. Sci., 35: 246-250, 1985.
48. Liu, C., Wang, X. D., Bronson, R. T., Smith, D. E., Krinsky, N. I., and Russell, R. M. Effects of physiological versus pharmacological β-carolene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis (Lond.), 21: 2245-2253, 2000.
49. Kvale, G., Bjelke, E., and Gait, J. J. Dietary habits and lung cancer risk. Int. J. Cancer, 31: 397-405, 1983.
50. Bond, G. G., Thompson, F. E., and Cook, R. R. Dietary vitamin A and lung cancer: results of a case-control study among chemical workers. Nutr. Cancer, 9: 109-121, 1987.
51. Le Marchand, L., Yoshizawa, C. N., Kolonel, L. N., Hankin, J. H., and Goodman, M. T. Vegelable consumption and lung cancer risk: a population-based case-control study in Hawaii. J. Natl. Cancer Inst. (Bethesda). 81: 1158-1164, 1989.
52. Knekl, P., Jarvinen, R., Seppanen, R., Rissanen, A., Aromaa, A., Heinonen, O. P., Albanes, D., Heinonen, M., Pukkala, E., and Teppo, L. Dietary antioxidants and the risk of lung cancer. Am. J. Epidemiol., 134: 471-479, 1991.
53. Harris, R. W., Key, T. J., Silcocks, P. B., Bull, D., and Wald, N. J. A case-control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr. Cancer. 15: 63-68, 1991.
54. Forman, M. R., Yao, S. X., Graubard, B. I., Qiao, Y. L., McAdams, M., Man, B. L., and Taylor, P. R. The effect of dietary intake of fruits and vegetables on the odds ratio of lung cancer among Yunnan tin miners. Int. J. Epidemiol., 21: 437-441, 1992.
55. Candelora, E. C., Stockwell, H. G., Armstrong, A. W., and Pinkham, P. A. Dietary intake and risk of lung cancer in women who never smoked. Nutr. Cancer. 17: 263-270, 1992.
56. Mayne, S. T., Janerich, D. T., Greenwald, P., Chorosl, S., Tucci, C., Zaman, M. B., Melamed, M. R., Kiely, M., and McKneally, M. F. Dietary β-carotene and lung cancer risk in U. S. nonsmokers. J. Natl. Cancer Inst. (Bethesda), 86: 33-38, 1994.
57. Agudo, A., Esteve, M. G., Pallares, C., Martinez-Ballarin, J., Fabregal, X., Malats, N., Machengs, I., Badia, A., and Gonzalez, C. A. Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain. Eur. J. Cancer. 33: 1256-1261, 1997.
58. Brennan, P., Fortes, C., Butler, J., Agudo, A., Benhamou, S., Darby, S., Gerken, M., Jokel, K. H., Kreuzer, M. Mallone, S., Nyberg, F., Pohlabeln, H., Ferro, G., and Boffelta, P. A multicenter case-control study of diet and lung cancer among non-smokers. Cancer Causes Control, 11: 49-58, 2000.
59. Michaud, D. S., Feskanich, D., Rimm, E. B., Colditz, G. A., Speizer, F. E., Willett, W. C., and Giovannucci, E. Intake of specific carotenoids and risk of lung cancer in 2 prospective U. S. cohorts. Am. J. Clin. Nutr., 72: 990-997, 2000.
60. Rajah, R., Valentinis, B., and Cohen, P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-bI on programmed cell death through a p53 and IGF-independent mechanism. J. Biol. Chem., 272: 12181-12188, 1997.
61. Bult, A. J. and Williams, A. C. IGFBP-3 and apoptosis: a license to kill? Apoptosis, 6: 199-205, 2001.
62. Bult, A. J., Fraley, K. A., Firth, S. M. and Baxter, R. C. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology, 143: 2693-2699, 2002.
63. Wei, W., Kim, Y., and Boudreau, N. Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988-1994. Am. J. Public Health, 91: 258-264, 2001.
64. Lu, Q. Y., Hung, J. C., Heber, D., Go, V. L., Reuter, V. E., Cordon-Cardo, C., Scher, H. I., Marshall, J. R., and Zhang. Z. F. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol. Biomark. Prev., 10: 749-756, 2001.
65. Vogt, T. M., Mayne, S. T., Graubard, B. I., Swanson, C. A., Sowell, A. L., Schoenberg, J. B., Swanson, G. M., Greenberg, R. S., Hoover, R. N., Hayes, R. B., and Ziegler, R. G. Serum lycopene, other serum carotenoids, and risk of prostate cancer in U. S. blacks and whites. Am. J. Epidemiol., 155: 1023-1032, 2002.
66. Hininger, I. A., Meyer-Wenger, A., Moser, U., Wright, A., Southon, S., Thurnham, D., Chopra, M., Van Den Berg, H., Olmedilla, B., Favier, A. E., and Roussel, A. M. No significant effects of lutein, lycopene or β-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J. Am. Coll. Nutr., 20: 232-238, 2001.
67. Schmitz, H. H., Poor, C. L., Wellman, R. B., and Erdman, J. W., Jr. Concentrations of selected carotenoids and vitamin A in human liver, kidney, and lung tissue. J. Nutr., 121: 1613-1621, 1991.
68. Hu, K., Liu, C., Russell, R. M., and Wang, X. D. Cigarette smoke exposure up-regulates carotene excentric cleaving enzyme, carotene-9′, 10′-monooxygenase, in the lungs of ferrets with or without lycopene supplementation. Cancer Epidemiol. Biomark. Prev., 11: I196s, 2003.
69. Liu, C., Russell, R. M., and Wang, X. D. Exposing ferrets to cigarette smoke and a pharmacological dose of β-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J. Nutr., 133: 173-179, 2003.
70. Liu, C., Russell, R. M., Seitz, H. K., and Wang, X. D. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology. 120: 179-189, 2001.